InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Featured in NetworkNewsAudio on Advancing 3D AI-Imaging Technologies
October 27, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) is spotlighted in a NetworkNewsAudio release titled “Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market,” highlighting its IzoView Breast CT Imaging System. Positioned between tomosynthesis and MRI, IzoView integrates high-resolution volumetric imaging with proprietary AI reconstruction for enhanced diagnostic precision. Built on over a decade […]
NetworkNewsAudio Announces Audio Press Release (APR) on Breast CT Imaging System Capitalizing on Proprietary AI Tech
October 27, 2025
AUSTIN, Texas, Oct. 27, 2025 (GLOBE NEWSWIRE) — via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market,” featuring Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF). To hear the NetworkNewsAudio version, visit https://nnw.fm/m5BU6 To read the original editorial, visit https://nnw.fm/7yoEs This integration of AI with volumetric imaging technologies, such as tomosynthesis, MRI […]
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Featured in NetworkNewsWire Editorial on AI-Driven Breast Cancer Imaging
October 24, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) announced its inclusion in a NetworkNewsWire (“NNW”) editorial titled “Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market.” The publication explores how artificial intelligence (AI) is reshaping medical imaging, particularly in breast cancer detection, where early and precise diagnosis remains critical to survival rates. Izotropic is […]
Izotropic Corporation’s (CSE: IZO) (OTCQB: IZOZF) Leverages AI with Next-Gen Breast CT Imaging System
October 24, 2025
NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) — via InvestorWire — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view […]
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) CEO Discusses IzoView Commercialization Strategy in New Departures Capital Interview
October 23, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company developing advanced imaging technologies for the detection and treatment of breast cancer, announced the release of a new video interview with CEO Bob Thast in partnership with Departures Capital. The discussion highlights Izotropic’s vision and near-term strategy for its flagship IzoView breast CT platform, […]
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Highlights Breast Cancer Awareness Month by Addressing Gaps in Screening and Advancing the IzoView Breast CT Solution
October 22, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device firm leading imaging-based solutions for better diagnosis, screening, and treatment of breast cancer patients, is bringing the challenges of current screening systems and the unique potential of the IzoView Breast CT Imaging solutions as part of efforts to mark Breast Cancer Awareness Month (ibn.fm/Hml57). Breast […]
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Featured in NetworkNewsWire Editorial on AI-Driven 3D Imaging for Breast Cancer Detection
October 22, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), developer of the IzoView Breast CT Imaging System, announces its inclusion in a NetworkNewsWire (“NNW”) editorial titled “Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market.” The piece highlights how artificial intelligence is transforming medical imaging, particularly in breast cancer diagnostics, where early and accurate detection […]
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System
October 22, 2025
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — via InvestorWire — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view […]
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Unveils IzoView: A Game-Changing Platform for Next-Gen Breast Cancer Detection
October 17, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) is leading a transformation in breast cancer screening with its flagship IzoView Breast CT Imaging System, a next-generation technology designed to overcome the long-standing limitations of traditional mammography. Unlike compression-based 2D imaging, IzoView delivers true 360-degree, 3D visualization without discomfort, enabling clearer detection—especially in dense breast tissue, which […]
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Advances AI-Powered Breast CT Innovation and Reinforces Its Commitment to Safer, Smarter Cancer Imaging
October 15, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) is changing how breast cancer imaging is done using its IzoView system, a CT platform designed for AI integration. Recent studies from the NIH show that there are increasing concerns about the radiation coming from CT scans. Izotropic’s technology presents a solution that helps optimize breast images while prioritizing dose […]
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Expands Commercialization Strategy with $375K Financing, Investor Awareness Agreements, and Breakthrough Personalized Radiation Dose Breast CT
October 8, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a leading medical device firm in the field of breast cancer imaging solutions, is speeding up its efforts towards commercializing its innovations. Izotropic recently made public significant progress in its IzoView Breast CT system, a feature designed to give patients a customized radiation dose ideal for their composition […]
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Highlights Need for Advanced 3D Imaging During Breast Cancer Awareness Month
October 8, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company developing imaging-based technologies for more accurate breast cancer screening, diagnosis, and treatment, marked Breast Cancer Awareness Month by emphasizing the limitations of current imaging tools and the significant opportunity for its flagship IzoView Breast CT Imaging System. With more than 2.3 million new breast […]
Izotropic Marks Breast Cancer Awareness Month by Highlighting Gaps in Care and the Need for IzoView Breast CT
October 8, 2025
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) — via IBN –Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, marks Breast Cancer Awareness Month by underscoring the persistent limitations in current breast cancer imaging […]
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): Anticipating Tomorrow’s Imaging Standards Today
September 26, 2025
In medical imaging, technology often races ahead of regulation. A recent proposal from the Centers for Medicare & Medicaid Services (CMS) underscores this tension: the agency is opting not to mandate radiation dose tracking for CT scans by 2027. While the decision reflects operational challenges hospitals face in meeting such requirements, it also highlights a […]
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Highlights AI Role in Breast Imaging With New Feature Article
September 25, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) announced the publication of a feature article on BreastCT.com titled “AI Is Reshaping Breast Imaging, and IzoView Was Built for What Comes Next.” The piece underscores the limitations of legacy systems and details how the Company’s flagship IzoView Breast CT Imaging System was purpose-built for AI-driven imaging. Key […]
AI in Breast Imaging: New BreastCT.com Article Examines IzoView’s Competitive Edge
September 25, 2025
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) — via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, is pleased to announce the publication of a new feature article on BreastCT.com titled “AI Is […]
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Integrates Radiation Dose Personalization into IzoView Breast CT System
September 23, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company focused on advanced breast cancer imaging technologies, announced the integration of a patent-pending radiation dose personalization feature into its IzoView Breast CT Imaging System. The innovation uses a radiation-free optical pre-scan and proprietary software to calculate customized dosing for each patient’s breast size, streamlining […]
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) CEO Featured in BMW Podcast Discussing Breakthrough Breast CT Imaging
September 23, 2025
A new episode of the BioMedWire Podcast shines a spotlight on Izotropic (CSE: IZO) (OTCQB: IZOZF) and its innovative approach to breast cancer imaging. Featuring IZO CEO Robert Thast, the podcast (ibn.fm/JUWtD) reveals how Izotropic’s proprietary Breast CT technology could transform early detection, improve patient outcomes and set the company on a trajectory toward commercial […]
Izotropic’s IzoView Breast CT the First in Category to Offer Patent-Pending Personalized Radiation Dose
September 23, 2025
– Patent-pending pre-scan technology enables custom radiation dose tailored to patient’s unique breast size and composition – – Feature aligns with personalized medicine trends driving the global breast imaging device market size to USD $8.69 billion by 2030 – – Integrated into the IzoView commercial model alongside modular engineering, compression-free imaging, and AI-driven image optimization […]
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Closes $375,000 Private Placement
September 19, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company developing imaging-based products for more accurate breast cancer screening, diagnosis and treatment, announced it has closed a non-brokered private placement of 1.5 million units at $0.25 per unit for gross proceeds of $375,000. Each unit includes one common share and one transferable warrant exercisable […]
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Launches FAQ Page to Enhance Transparency and Investor Engagement
September 16, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company advancing imaging-based products for the detection and treatment of breast cancer, has launched a new Frequently Asked Questions page on its corporate website at www.izocorp.com/faq. The resource provides accessible information on the company’s IzoView Breast CT Imaging System, development milestones, and competitive positioning, addressing […]
Izotropic Publishes New FAQ Page for Investors, Analysts, and Healthcare Decision-Makers
September 16, 2025
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) — via IBN –Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces the launch of a new Frequently Asked Questions (“FAQ”) page on its […]
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): When 15 Years of Data Creates Unassailable AI Advantage
September 12, 2025
The medical imaging industry stands at a pivotal juncture. Artificial intelligence promises to revolutionize diagnostics, yet most AI applications in CT imaging remain stuck in theory rather than practice. Conventional AI denoising tools either demand prohibitive computing power, compromise diagnostic clarity, or require impractical training datasets that increase patient exposure. The gap between AI’s promise […]
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): Exclusive CADx Patent Positions IzoView as First-Mover in AI-Enhanced Breast CT
September 11, 2025
The AI Integration Challenge in Medical Imaging Artificial intelligence has long promised to revolutionize radiology, but most applications remain stuck between theoretical potential and real-world limitations. CADx systems can enhance detection, yet they face hurdles: lack of specialized datasets, workflow disruptions, and intellectual property barriers. In breast imaging, the stakes are higher. Nearly half of […]
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Featured in MarketScreener Editorial on Targeted AI Applications
September 11, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company advancing imaging-based products for the more accurate screening, diagnosis and treatment of breast cancers, announced its sponsored placement in a MarketScreener.com editorial titled From Healthcare to Automation: Investing In Next AI Wave. The article discusses the growing adoption of specialized AI applications across industries […]
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): Advancing Dedicated Breast Imaging at a Market Crossroads
September 8, 2025
Imaging’s Stagnation Meets a New Wave of Purpose-Built Devices For decades, breast cancer screening has relied heavily on mammography, a compression-based modality that, while valuable, carries persistent shortcomings. Dense breast tissue, which affects nearly half of women, often obscures lesions, leading to missed cancers or unnecessary callbacks. These limitations have fueled billions in annual healthcare […]
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) CEO Featured on IBN’s BioMedWire Podcast
September 4, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company developing the IzoView Breast CT Imaging System, was featured in the latest episode of IBN’s BioMedWire Podcast. CEO Robert Thast discussed the company’s mission to improve early breast cancer detection, noting IzoView’s ability to identify cancers as small as 2 millimeters compared to the […]
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Robert Thast, CEO of Izotropic Corp.
September 4, 2025
AUSTIN, Texas, Sept. 04, 2025 (GLOBE NEWSWIRE) — via IBN — IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The BioMedWire Podcast delivers dynamic interviews […]
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Secures Exclusive U.S. Patent for Computer-Aided Diagnosis with Breast CT
September 3, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company commercializing imaging-based technologies for improved breast cancer screening, diagnosis, and treatment, announced the issuance of the only U.S. patent for computer-aided diagnosis (CADx) with breast CT, covered under the Company’s exclusive global license agreement with the Regents of the University of California. CADx is […]
Izotropic Secures Exclusive Rights to Patented Computer-Aided Diagnosis for Breast CT
September 3, 2025
– U.S. patent protection covers computer-aided diagnosis (“CADx”) with breast CT – – Izotropic holds the exclusive rights to this patent and breast CT technology under global license agreement – – CADx upgrade to be integrated into IzoView Breast CT post-initial market launch, feature may be offered as an upgrade incentive to early adopters – […]
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): Building Market Awareness Through Strategic Education Platform
September 2, 2025
The Pre-Commercial Challenge: Educating Markets on Breakthrough Technology Medical device companies developing breakthrough technologies face a fundamental commercialization challenge beyond regulatory approval: market education. When innovations represent genuine advances over existing standards of care, successful adoption requires comprehensive stakeholder education across patients, clinicians, and healthcare administrators. Izotropic (CSE: IZO) (OTCQB: IZOZF) launched BreastCT.com as a […]
Izotropic’s AI Breakthrough Positions IzoView to Redefine Breast CT Imaging Standards
August 28, 2025
– Proprietary algorithm positions IzoView to redefine global standards and expectations for image quality and safety in breast CT – – Trained on 15 years of specialized breast CT data and protected as a trade secret, giving Izotropic a durable competitive edge – – AI enhances IzoView’s image quality by reducing CT image noise without increasing […]
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Integrates Proprietary AI Algorithm into Breast CT Imaging System
August 28, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company advancing imaging-based products for breast cancer care, announced the integration of its proprietary AI-based machine-learning reconstruction algorithm into its flagship IzoView Breast CT Imaging System. Developed in collaboration with The Johns Hopkins University School of Medicine, the algorithm is designed to improve image quality […]
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Unveils Comprehensive Brand Identity Transformation to Position Company for Commercial Launch
August 26, 2025
As Izotropic (CSE: IZO) (OTCQB: IZOZF) positions itself to capture a share of the $8.7 billion global breast imaging market projected by 2030 (ibn.fm/tRIr4), the company has unveiled a strategic brand transformation that signals its readiness to commercialize two decades of breakthrough medical research. Izotropic holds exclusive global licensing rights to revolutionary breast CT technology […]
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Announces $300K Private Placement and Warrant Extension
August 26, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company focused on imaging-based products for breast cancer care, announced plans for a non-brokered private placement of up to 1.2 million units at $0.25 each to raise gross proceeds of up to $300,000. Each unit will include one common share and one transferable warrant exercisable […]
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Launches BreastCT.com to Advance Awareness of Dedicated Breast CT Technology
August 19, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company commercializing imaging-based products for more accurate breast cancer screening, diagnoses, and treatment, announced the launch of BreastCT.com, a new online platform supporting its awareness initiatives. The site serves as a central educational resource on dedicated breast CT technology and Izotropic’s IzoView Breast CT Imaging […]
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): How a $500K Device Could Reshape the $8.7 Billion Breast Imaging Market
August 19, 2025
Every year, outdated imaging technologies underperform for the roughly half of women undergoing breast cancer screening who have dense breast tissue. Dense breast tissue creates a fundamental imaging challenge in compression-based imaging, like mammography, where overlapping structures can mask cancers, potentially delaying diagnosis when cancers are small and in their most treatable stages. This limitation […]
BreastCT.com Debuts as Go-To Resource for Breast CT Technology & Izotropic’s IzoView Device
August 19, 2025
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) — via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces the launch of BreastCT.com, a new online platform supporting the Company’s awareness initiatives. BreastCT.com has […]
InvestorNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Launches New Corporate Website and Brand Identity
August 12, 2025
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company focused on innovative imaging technologies for improved breast cancer screening, diagnosis and treatment, has unveiled a redesigned corporate website at izocorp.com along with a refreshed brand identity. The updated site offers streamlined navigation, expanded content and multimedia resources that communicate the Company’s value proposition […]
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF): The Cancer Detection Revolution That Could Make Breast Cancer Deaths Preventable
August 8, 2025
The medical community stands at the threshold of what could become the most significant advancement in cancer detection since the introduction of mammography over half a century ago. While survival rates for many cancers have improved dramatically through better treatments, the fundamental challenge of early detection remains largely unchanged. Current screening technologies, despite decades of […]